Clinical Trial Update: Validation of a Kinetic Model of Erlotinib

View source ↗

Summary

This clinical trial update covers validation of a pharmacokinetic model for erlotinib in lung cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Lung Cancer | Status: UNKNOWN